NeuroTidal Diagnostics bridges the gap in Parkinson’s diagnostics
NeuroTidal Diagnostics is developing FibrilRuler, a blood test that measures amyloid fibrils to help diagnose and monitor Parkinson’s disease.
Stay updated on the latest breakthroughs, funding news, and success stories from the founders and researchers at Utrecht Science Park.
NeuroTidal Diagnostics is developing FibrilRuler, a blood test that measures amyloid fibrils to help diagnose and monitor Parkinson’s disease.
Four UtrechtInc startups have made it into the KVK Innovation Top 100 2026: UCANACT, Verticai, Lifechaingers and Sealed Cycle. Public votes count for 20% of the final ranking. Vote before October 19 and don’t forget to confirm your vote.
UCANACT has closed €800K in pre-seed funding to develop a brain-computer interface that translates brain signals into computer actions and speech - helping people with severe motor disabilities communicate independently at home
Are you interested in entrepreneurship and good at connecting with people? We're looking for a student to join our Student Startup Scout team and help us find the next generation of student founders.
Lumox in the Spotlight — Killing Cancer with Light on BNR Radio Our very own Lumox is making waves — this time on national radio
Crossroads 2026 is done and it was a good one. On July 8 we brought the Utrecht startup ecosystem together at DotSlash for a full day of pitches, conversations, and the kind of energy you only get when founders, investors, and ecosystem builders are all in the same room.
Tagetto is a deal intelligence company focused on M&A. They build AI-powered market mapping and pipeline tools in close collaboration with corporate development and M&A teams, for target sourcing, deal tracking, or any other stage where finding and closing the right acquisition matters.
The clinical countdown has started. Are you in? Lumox, one of our startups, just secured €4.5M+ from KWF Kankerbestrijding to fund the first clinical study of their light-activated precision cancer therapy. The roadmap to patients is now a timeline.
ObsessLess was named runner-up for the NN Social Innovation Startup Award at Hello Tomorrow, founded by Mourice Schuurmans and Adrian Pavel. The recognition comes with a €35,000 grant aimed at helping more people get timely support, addressing long wait times that many currently face for proper OCD treatment.